Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PEPG · against 193 other Healthcare companies of similar size
Ranked #126 of 194 · scores higher than 9% of peers
Bars: peers in each 10-point band of the valuation score69 peers with a valuation score of 0–9, including PEPG · Click a bar to see the companies
Mainly because of its EBITDA yield, earnings yield and free cash flow yield, which are weaker than most Healthcare peers.
| Metric | PEPG | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 176 reported | -41.9% | -6.5% | 24% | 30% | |
| EBITDA yieldHigher is better · 202 reported | -108.3% | 0.9% | 12% | 50% | |
| Free cash flow yieldHigher is better · 126 reported | -40.8% | -14.4% | 26% | 20% | |
| Book yieldHigher is better · 183 reported | 70.2% | 67.1% | 52% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 834M HKD (≈$107M) | 99 | 57 | |
| 1 | 1.4B HKD (≈$181M) | 99 | 61 | |
| 1 | 29.0B JPY (≈$197M) | 99 | 56 | |
| 1 | 592M ILS (≈$160M) | 99 | 84 | |
| 126 | 334M USD | 8 | 49 | |
| 126 | 253M USD | 8 | 15 | |
| 126 | 107M USD | 8 | 26 | |
| 126 | 124M USD | 8 | 31 | |
| 126 | 170M USD | 8 | 35 | |
| 126 | 302M USD | 8 | 42 | |
| 126 | 139M USD | 8 | 32 | |
| 126 | 223M USD | 8 | 34 | |
| 126 | 303M USD | 8 | 27 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score